Cite
Studies from IRCCS Regina Elena National Cancer Institute Update Current Data on Mesotheliomas (Dhea-s, Androstenedione, 17-8-estradiol Signature As Novel Biomarkers for Early Prediction of Risk of Malignant Pleural Mesothelioma Linked To...).
MLA
“Studies from IRCCS Regina Elena National Cancer Institute Update Current Data on Mesotheliomas (Dhea-s, Androstenedione, 17-8-Estradiol Signature As Novel Biomarkers for Early Prediction of Risk of Malignant Pleural Mesothelioma Linked To...).” Drug Week, July 2024, p. 3040. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=178118155&authtype=sso&custid=ns315887.
APA
Studies from IRCCS Regina Elena National Cancer Institute Update Current Data on Mesotheliomas (Dhea-s, Androstenedione, 17-8-estradiol Signature As Novel Biomarkers for Early Prediction of Risk of Malignant Pleural Mesothelioma Linked To...). (2024). Drug Week, 3040.
Chicago
“Studies from IRCCS Regina Elena National Cancer Institute Update Current Data on Mesotheliomas (Dhea-s, Androstenedione, 17-8-Estradiol Signature As Novel Biomarkers for Early Prediction of Risk of Malignant Pleural Mesothelioma Linked To...).” 2024. Drug Week, July, 3040. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=178118155&authtype=sso&custid=ns315887.